Page last updated: 2024-08-22

fluorine and 2019 Novel Coronavirus Disease

fluorine has been researched along with 2019 Novel Coronavirus Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (100.00)	2.80

Authors

Authors	Studies
Gandhi, S; Mahari, S; Roberts, A; Shahdeo, D	1
Albericio, F; de la Torre, BG	1
Alves de Mesquita, M; Bosch, JJ; Brenner, A; Brotman, DJ; Butowski, NA; Campian, JL; Cao, JJ; Cao, Z; Chi, B; Cloughesy, TF; Cohen, YC; de Groot, JF; Ellingson, BM; Fendel, R; Fotin-Mleczek, M; Francischetti, IMB; Gabor, JJ; Gong, F; He, L; Hooper, JE; Jani, J; Kickler, TS; Knight, D; Kreidenweiss, A; Kremsner, PG; Kroidl, A; Leroux-Roels, G; Leroux-Roels, I; Levine, J; Lowenton-Spier, N; Lucore, C; Mann, P; Mehrotra, B; Minei, TR; Muehlbauer, S; Mueller, SO; Nguyen, J; Oostvogels, L; Patel, K; Pollack, S; Qian, Y; Quintini, G; Raymond, C; Rizvi, S; Schindler, C; Schlossman, J; Schönborn-Kellenberger, O; Schunk, M; Shmueli, SF; Siddiqui, Z; Stern, J; Thakore, A; Toomer, K; Vahrenhorst, D; Velavan, TP; Verstraeten, T; Walz, L; Wang, C; Wen, PY; Wolz, OO; Xia, J; Zach, L; Zeng, D; Zhang, Y; Zhu, H	1

Reviews

1 review(s) available for fluorine and 2019 Novel Coronavirus Disease

Article	Year
The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland), 2023, Jan-20, Volume: 28, Issue:3 Topics: Antibodies, Monoclonal; Biological Factors; Biological Products; COVID-19; Drug Approval; Drug Industry; Fluorine; Humans; Immunoconjugates; Oligonucleotides; Peptides; Pharmaceutical Preparations; United States; United States Food and Drug Administration	2023

Article

Year

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules.

Molecules (Basel, Switzerland), 2023, Jan-20, Volume: 28, Issue:3

Topics: Antibodies, Monoclonal; Biological Factors; Biological Products; COVID-19; Drug Approval; Drug Industry; Fluorine; Humans; Immunoconjugates; Oligonucleotides; Peptides; Pharmaceutical Preparations; United States; United States Food and Drug Administration

2023

Trials

1 trial(s) available for fluorine and 2019 Novel Coronavirus Disease

Article	Year
EClinicalMedicine, 2021, Volume: 39 Topics: Adolescent; Adult; Antibodies, Viral; Cilia; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Double-Blind Method; Fluorescent Dyes; Fluorine; Humans; Immunization, Passive; Immunogenicity, Vaccine; Lipids; MCF-7 Cells; Middle Aged; Molecular Structure; Nanoparticles; Nitriles; Pyrenes; RNA, Messenger; SARS-CoV-2; Silver; Vaccines; Young Adult	2021

Other Studies

1 other study(ies) available for fluorine and 2019 Novel Coronavirus Disease

Article	Year
Label-free detection of SARS-CoV-2 Spike S1 antigen triggered by electroactive gold nanoparticles on antibody coated fluorine-doped tin oxide (FTO) electrode. Analytica chimica acta, 2021, Dec-15, Volume: 1188 Topics: Biosensing Techniques; COVID-19; Electrodes; Fluorine; Gold; Humans; Immunoassay; Metal Nanoparticles; SARS-CoV-2; Spectroscopy, Fourier Transform Infrared; Spike Glycoprotein, Coronavirus; Tin Compounds	2021

Article

Year

Label-free detection of SARS-CoV-2 Spike S1 antigen triggered by electroactive gold nanoparticles on antibody coated fluorine-doped tin oxide (FTO) electrode.

Analytica chimica acta, 2021, Dec-15, Volume: 1188

Topics: Biosensing Techniques; COVID-19; Electrodes; Fluorine; Gold; Humans; Immunoassay; Metal Nanoparticles; SARS-CoV-2; Spectroscopy, Fourier Transform Infrared; Spike Glycoprotein, Coronavirus; Tin Compounds

2021